» Articles » PMID: 8675684

Role of Lysophosphatidylcholine in the Inhibition of Endothelial Cell Motility by Oxidized Low Density Lipoprotein

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1996 Jun 15
PMID 8675684
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cell (EC) movement is required for the development and repair of blood vessels. We have previously shown that LDL oxidized by transition metals almost completely suppressed the wound-healing migratory response of vascular EC in vitro. We now report that lysophosphatidylcholine (lysoPC), a lipid component of oxidized LDL, has an important role in the antimigratory activity of the lipoprotein. Purified 1-palmitoyl lysoPC inhibited movement with a half-maximal activity at 12-15 micrometers, and near complete inhibition at 20 micrometers; the inhibitory concentration of lysoPC was consistent with its abundance in oxidized LDL. The inhibition was not due to cytotoxicity since protein synthesis was unaffected and since EC movement was restored after removal of lysoPC. Lysophospholipid activity was dependent on lipid structure. LysoPC's containing 1-position C16 or C18 saturated fatty acids were antimigratory, but those containing C < or = 14 saturated fatty acids or polyunsaturated fatty acids were not. The activity of 1-palmitoyl lysolipids with various head groups was examined. Lysophosphatidylinositol was more antimigratory than lysophosphatidylglycerol and lysophosphatidylcholine, which were more potent than lysophosphatidylserine and lysophosphatidylethanolamine. Monoglyceride was inactive while lysophosphatidate had promigratory activity. These results are consistent with head group size rather than charge as a critical determinant of activity. To show that lysophospholipids within an intact lipoprotein were active, LDL was treated with bee venom phospholipase A2 (PLA2). The modified lipoprotein inhibited EC movement to the same extent as iron-oxidized LDL and antimigratory activity correlated with the amount of lysoPC formed. To determine antimigratory activity of lysoPC present in oxidized LDL, lipid extracts from oxidized LDL were fractionated by normal phase HPLC. The fraction comigrating with lysoPC had nearly the same activity as the total extract confirming that lysoPC (or a co-eluting lipid) was a major antimigratory molecule in oxidized LDL. These studies demonstrate that lysoPC in oxidized LDL limit EC wound healing responses in vitro, and suggest a possible role for lysolipids in limiting endothelial regeneration after a denuding injury in vivo.

Citing Articles

Possible Involvement of Lysophospholipids in Severe Asthma as Novel Lipid Mediators.

Kume H, Kazama K, Sato R, Sato Y Biomolecules. 2025; 15(2).

PMID: 40001485 PMC: 11852450. DOI: 10.3390/biom15020182.


p38 MAPK activation and STIM1-Orai3 association mediate TRPC6 externalization.

Chaudhuri P, Putta P, Rosenbaum M, Graham L Am J Physiol Cell Physiol. 2023; 324(6):C1199-C1212.

PMID: 37093037 PMC: 10228675. DOI: 10.1152/ajpcell.00425.2022.


iPLA2 inhibition blocks LysoPC-induced TRPC6 externalization and promotes Re-endothelialization of carotid injuries in hypercholesterolemic mice.

Putta P, Chaudhuri P, Guardia-Wolff R, Rosenbaum M, Graham L Cell Calcium. 2023; 112:102734.

PMID: 37030190 PMC: 10234282. DOI: 10.1016/j.ceca.2023.102734.


p85α regulatory subunit isoform controls PI3-kinase and TRPC6 membrane translocation.

Chaudhuri P, Putta P, Graham L, Rosenbaum M Cell Calcium. 2023; 111:102718.

PMID: 36934559 PMC: 10084841. DOI: 10.1016/j.ceca.2023.102718.


Albumin is an interface between blood plasma and cell membrane, and not just a sponge.

van de Wouw J, Joles J Clin Kidney J. 2022; 15(4):624-634.

PMID: 35371452 PMC: 8967674. DOI: 10.1093/ckj/sfab194.


References
1.
Rosen E, Carley W, Goldberg I . Scatter factor regulates vascular endothelial cell motility. Cancer Invest. 1990; 8(6):647-50. DOI: 10.3109/07357909009018936. View

2.
Kalant N, McCormick S, Parniak M . Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen. Arterioscler Thromb. 1991; 11(5):1322-9. DOI: 10.1161/01.atv.11.5.1322. View

3.
Bjornsson T, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin T . Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991; 88(19):8651-5. PMC: 52567. DOI: 10.1073/pnas.88.19.8651. View

4.
Yla-Herttuala S . Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Med. 1991; 23(5):561-7. DOI: 10.3109/07853899109150518. View

5.
Schmidt K, Klatt P, Graier W, Kostner G, Kukovetz W . High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase. Biochem Biophys Res Commun. 1992; 182(1):302-8. DOI: 10.1016/s0006-291x(05)80145-7. View